||
https://blog.sciencenet.cn/blog-3506747-1338822.html
文献分析
http://www.pubmedplus.cn/P/SearchQuickResult?wd=794468b1-9ddf-4089-98b9-1c159d11c610
01. | 2022 | 10 篇 | 8.850% |
02. | 2021 | 65 篇 | 57.522% |
03. | 2020 | 37 篇 | 32.743% |
04. | 2019 | 1 篇 | 0.885% |
01. | front immunol | 16 篇 | 14.159% |
02. | int j mol sci | 8 篇 | 7.080% |
03. | j immunother cancer | 7 篇 | 6.195% |
04. | j hematol oncol | 3 篇 | 2.655% |
05. | trends cancer | 3 篇 | 2.655% |
06. | acc chem res | 2 篇 | 1.770% |
07. | adv healthc mater | 2 篇 | 1.770% |
08. | biomolecules | 2 篇 | 1.770% |
09. | cancer discov | 2 篇 | 1.770% |
10. | cell mol immunol | 2 篇 | 1.770% |
01. | 美国 | 41 篇 | 36.283% |
02. | 中国 | 36 篇 | 31.858% |
03. | 法国 | 10 篇 | 8.850% |
04. | 英国 | 10 篇 | 8.850% |
05. | 西班牙 | 6 篇 | 5.310% |
06. | 日本 | 5 篇 | 4.425% |
07. | 意大利 | 5 篇 | 4.425% |
08. | 澳大利亚 | 4 篇 | 3.540% |
09. | 加拿大 | 4 篇 | 3.540% |
10. | 韩国 | 3 篇 | 2.655% |
01. | 中国北京 | 5 篇 | 4.425% |
02. | 中国广州 | 5 篇 | 4.425% |
03. | 中国上海 | 4 篇 | 3.540% |
04. | 中国苏州 | 3 篇 | 2.655% |
05. | 中国成都 | 3 篇 | 2.655% |
06. | 中国天津 | 2 篇 | 1.770% |
07. | 中国大连 | 2 篇 | 1.770% |
08. | 中国长春 | 2 篇 | 1.770% |
09. | 中国南京 | 2 篇 | 1.770% |
10. | 中国徐州 | 2 篇 | 1.770% |
01. | Immune Checkpoint Inhibitors | 113 篇 | 100.000% |
02. | Immunotherapy | 113 篇 | 100.000% |
03. | Neoplasms | 113 篇 | 100.000% |
04. | Tumor Microenvironment | 113 篇 | 100.000% |
05. | Humans | 110 篇 | 97.345% |
06. | Animals | 61 篇 | 53.982% |
07. | Mice | 26 篇 | 23.009% |
08. | Programmed Cell Death 1 Receptor | 19 篇 | 16.814% |
09. | B7-H1 Antigen | 17 篇 | 15.044% |
10. | Drug Resistance, Neoplasm | 17 篇 | 15.044% |
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-4-24 09:03
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社